Elevated C-reactive protein (CRP) levels have previously been described before the onset of type 2 diabetes and gestational diabetes. We hypothesized that inflammation, as reflected by elevated ...
Elevated baseline C-reactive protein levels correlate with a reduced clinical response to adalimumab, despite the drug's overall efficacy. Patients with higher inflammation levels may experience ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback